Precigen Statistics
Total Valuation
Precigen has a market cap or net worth of $1.20 billion. The enterprise value is $1.15 billion.
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Precigen has 297.97 million shares outstanding. The number of shares has increased by 16.06% in one year.
| Current Share Class | 297.97M |
| Shares Outstanding | 297.97M |
| Shares Change (YoY) | +16.06% |
| Shares Change (QoQ) | +0.87% |
| Owned by Insiders (%) | 14.61% |
| Owned by Institutions (%) | 27.28% |
| Float | 122.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 267.87 |
| Forward PS | 16.63 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 264.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.71
| Current Ratio | 2.71 |
| Quick Ratio | 2.60 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -31,484.00 |
Financial Efficiency
Return on equity (ROE) is -668.03% and return on invested capital (ROIC) is -242.10%.
| Return on Equity (ROE) | -668.03% |
| Return on Assets (ROA) | -67.44% |
| Return on Invested Capital (ROIC) | -242.10% |
| Return on Capital Employed (ROCE) | -120.01% |
| Revenue Per Employee | $30,350 |
| Profits Per Employee | -$870,629 |
| Employee Count | 143 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -72,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +378.28% in the last 52 weeks. The beta is 1.61, so Precigen's price volatility has been higher than the market average.
| Beta (5Y) | 1.61 |
| 52-Week Price Change | +378.28% |
| 50-Day Moving Average | 3.86 |
| 200-Day Moving Average | 2.17 |
| Relative Strength Index (RSI) | 57.12 |
| Average Volume (20 Days) | 4,730,900 |
Short Selling Information
The latest short interest is 32.04 million, so 10.75% of the outstanding shares have been sold short.
| Short Interest | 32.04M |
| Short Previous Month | 37.75M |
| Short % of Shares Out | 10.75% |
| Short % of Float | 26.13% |
| Short Ratio (days to cover) | 5.47 |
Income Statement
In the last 12 months, Precigen had revenue of $4.34 million and -$124.50 million in losses. Loss per share was -$0.43.
| Revenue | 4.34M |
| Gross Profit | -52.67M |
| Operating Income | -94.45M |
| Pretax Income | -124.57M |
| Net Income | -124.50M |
| EBITDA | -91.86M |
| EBIT | -94.45M |
| Loss Per Share | -$0.43 |
Full Income StatementBalance Sheet
The company has $59.75 million in cash and $5.15 million in debt, giving a net cash position of $54.60 million or $0.18 per share.
| Cash & Cash Equivalents | 59.75M |
| Total Debt | 5.15M |
| Net Cash | 54.60M |
| Net Cash Per Share | $0.18 |
| Equity (Book Value) | -5.90M |
| Book Value Per Share | -0.12 |
| Working Capital | 39.56M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$66.28 million and capital expenditures -$3.50 million, giving a free cash flow of -$69.78 million.
| Operating Cash Flow | -66.28M |
| Capital Expenditures | -3.50M |
| Free Cash Flow | -69.78M |
| FCF Per Share | -$0.23 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -2,176.31% |
| Pretax Margin | -2,870.32% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Precigen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.06% |
| Shareholder Yield | -16.06% |
| Earnings Yield | -10.34% |
| FCF Yield | -5.80% |
Analyst Forecast
The average price target for Precigen is $7.50, which is 86.57% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.50 |
| Price Target Difference | 86.57% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 166.05% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Precigen has an Altman Z-Score of -30.35 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -30.35 |
| Piotroski F-Score | 3 |
